Ftse Mib
34.127,62
-0,72%
DAX
19.906,08
-0,49%
S&P 500
5.942,47
1,26%
NASDAQ
19.621,68
1,77%
Bitcoin
98.085,14
-0,13%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Sagiment Biosciences Inc (SGMT) Sagiment Biosciences Inc (SGMT) Notizie

SGMT

Sagiment Biosciences (SGMT)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:SGMT
DataOraFonteTitoloSimboloCompagnia
02/01/202514:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SGMTSagiment Biosciences Inc
15/11/202401:55Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:SGMTSagiment Biosciences Inc
14/11/202423:05Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:SGMTSagiment Biosciences Inc
14/11/202414:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SGMTSagiment Biosciences Inc
27/08/202406:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:SGMTSagiment Biosciences Inc
15/08/202423:27Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:SGMTSagiment Biosciences Inc
05/08/202422:09Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SGMTSagiment Biosciences Inc
05/08/202422:06Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:SGMTSagiment Biosciences Inc
23/07/202422:24Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:SGMTSagiment Biosciences Inc
13/06/202412:07Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:SGMTSagiment Biosciences Inc
25/03/202412:00GlobeNewswire Inc.Sagimet Biosciences Announces Appointment of Tim Walbert and Paul Hoelscher to its Board of DirectorsNASDAQ:SGMTSagiment Biosciences Inc
25/03/202411:15GlobeNewswire Inc.Sagimet Biosciences Reports Full Year 2023 Financial Results and Provides Corporate UpdatesNASDAQ:SGMTSagiment Biosciences Inc
29/02/202414:00GlobeNewswire Inc.Sagimet Biosciences to Participate in Two Upcoming Investor ConferencesNASDAQ:SGMTSagiment Biosciences Inc
15/02/202400:10Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:SGMTSagiment Biosciences Inc
26/01/202402:58GlobeNewswire Inc.Sagimet Biosciences Announces Pricing of Public Offering of Series A Common StockNASDAQ:SGMTSagiment Biosciences Inc
24/01/202412:08Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:SGMTSagiment Biosciences Inc
23/01/202423:45GlobeNewswire Inc.Sagimet Biosciences Announces Proposed Public Offering of Series A Common StockNASDAQ:SGMTSagiment Biosciences Inc
23/01/202423:31Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:SGMTSagiment Biosciences Inc
22/01/202413:00GlobeNewswire Inc.Sagimet Biosciences Announces Positive Topline Results from Phase 2b FASCINATE-2 Clinical Trial of Denifanstat in Biopsy-Confirmed F2/F3 NASHNASDAQ:SGMTSagiment Biosciences Inc
04/12/202314:00GlobeNewswire Inc.Sagimet Biosciences to Participate in the First Annual Goldman Sachs Catalyst ClinicNASDAQ:SGMTSagiment Biosciences Inc
28/11/202314:00GlobeNewswire Inc.Sagimet Biosciences Announces Oral Presentation of Preclinical Results of FASN Inhibitor in Combination with Semaglutide at the 7th Obesity and NASH Drug Development SummitNASDAQ:SGMTSagiment Biosciences Inc
22/11/202314:00GlobeNewswire Inc.Sagimet Biosciences to Present at the 35th Annual Piper Sandler Healthcare ConferenceNASDAQ:SGMTSagiment Biosciences Inc
13/11/202314:00GlobeNewswire Inc.Sagimet Biosciences Reports Third Quarter 2023 Financial Results and Provides Corporate UpdatesNASDAQ:SGMTSagiment Biosciences Inc
10/11/202314:30GlobeNewswire Inc.Sagimet Biosciences Presents Preclinical Results Supporting the Therapeutic Potential of its FASN inhibitor in Combination with Semaglutide and a Comprehensive Lipidomic Analysis of Interim FASCINATE-2 Data at AASLD - The Liver Meeting® 2023NASDAQ:SGMTSagiment Biosciences Inc
24/10/202317:00GlobeNewswire Inc.Sagimet Biosciences Announces Acceptance of Two Abstracts at AASLD - The Liver Meeting® 2023NASDAQ:SGMTSagiment Biosciences Inc
18/10/202322:05GlobeNewswire Inc.Sagimet Biosciences To Present at the H.C. Wainwright 7th Annual NASH Investor ConferenceNASDAQ:SGMTSagiment Biosciences Inc
27/09/202322:05GlobeNewswire Inc.Sagimet Biosciences Announces Completion of Enrollment of 120 Patients for Phase 3 Clinical Trial by Its Partner Ascletis of Denifanstat Combined with Bevacizumab for Treatment of Recurrent GlioblastomaNASDAQ:SGMTSagiment Biosciences Inc
21/08/202322:02GlobeNewswire Inc.Sagimet Biosciences Reports Second Quarter 2023 Financial Results and Provides Corporate UpdatesNASDAQ:SGMTSagiment Biosciences Inc
15/08/202322:04GlobeNewswire Inc.Sagimet Biosciences Announces Closing of Underwriters’ Option to Purchase Additional Shares of Series A Common Stock in Connection with its Upsized Initial Public OfferingNASDAQ:SGMTSagiment Biosciences Inc
20/07/202322:05GlobeNewswire Inc.Sagimet Biosciences Announces Leadership ChangesNASDAQ:SGMTSagiment Biosciences Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:SGMT

La tua Cronologia

BIT
STLAM
Stellantis NV
BIT
ENI
Eni
BIT
ISP
Intesa Sanpaolo
BIT
UCG
Unicredit
BIT
ENEL
Enel
BIT
SPM
Saipem
BIT
CPR
Davide Campari
BIT
STMMI
ST Microelectronics
BIT
RACE
Ferrari NV
BIT
BPE
Bper Banca
BIT
TIT
Telecom Italia
BIT
IVG
Iveco Group NV
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
TEN
Tenaris
BIT
MONC
Moncler
BIT
PRY
Prysmian
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network